scholarly article | Q13442814 |
P356 | DOI | 10.1017/S0033291718003811 |
P698 | PubMed publication ID | 30563582 |
P50 | author | Joanna Moncrieff | Q16732770 |
P2093 | author name string | Sandra Steingard | |
P2860 | cites work | Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? | Q28109603 |
Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research | Q30692570 | ||
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). | Q34018491 | ||
Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study | Q34051101 | ||
Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial. | Q34075734 | ||
Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study | Q34254903 | ||
Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials | Q34441060 | ||
Antipsychotic treatment and mortality in schizophrenia | Q35369872 | ||
The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia | Q38803633 | ||
Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis | Q38918200 | ||
Long-term antipsychotic use and its association with outcomes in schizophrenia - the Northern Finland Birth Cohort 1966. | Q39678156 | ||
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study | Q43198845 | ||
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia. | Q52604209 | ||
Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial. | Q52650011 | ||
What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? | Q55023835 | ||
Early Medication Discontinuation on Long-term Recovery Outcome in First-Episode Psychosis | Q57612290 | ||
Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database | Q89229446 | ||
P304 | page(s) | 1-4 | |
P577 | publication date | 2018-12-19 | |
P1433 | published in | Psychological Medicine | Q7256364 |
P1476 | title | A critical analysis of recent data on the long-term outcome of antipsychotic treatment |
Q97521512 | Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder |
Q103834527 | Misleading information about antipsychotics |
Q95579730 | Protecting physical health in people with mental illness |
Q90067070 | The association between family dysfunction and admission to an acute mental health inpatient unit: a prospective study |
Search more.